Agilent Technologies, Inc. (NYSE:A – Get Free Report) has been given an average recommendation of “Buy” by the fifteen brokerages that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $163.7143.
Several equities research analysts have issued reports on A shares. Barclays lowered their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. UBS Group lowered their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. TD Cowen lowered their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th.
View Our Latest Analysis on Agilent Technologies
Institutional Trading of Agilent Technologies
Agilent Technologies Stock Up 0.2%
Shares of A opened at $115.01 on Friday. The firm has a market capitalization of $32.50 billion, a P/E ratio of 25.39, a P/E/G ratio of 2.42 and a beta of 1.22. Agilent Technologies has a 12-month low of $107.07 and a 12-month high of $160.27. The firm has a fifty day moving average price of $114.77 and a 200-day moving average price of $129.56. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts expect that Agilent Technologies will post 5.95 earnings per share for the current year.
Agilent Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s payout ratio is 22.52%.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Read More
- Five stocks we like better than Agilent Technologies
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
